| 专论编号 | 物质名称 | 证书持有人 | 持有人ORG-ID和LOC-ID | 证书编号 | 发布日期 | 证书状态 | 到期续期 | 证书结束日期 | 证书类型 | 上一程序的结束日期 | 历史数据 程序类型|结论|日期 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1444 | Macrogols, Type 4000 | NANJING WELL PHARMACEUTICAL GROUP CO., LTD. Nanjing CN | 100051565;100090508 | CEP 2025-274 - Rev 00 | 2026/02/06 | Valid | 06/02/2031 | Chemical | 2026/02/06 | New application|CEP granted|06/02/2026 | |
| 2771 | Ibandronate sodium monohydrate | MAPRIMED S.A. Buenos Aires AR | 100012039;100018552 | CEP 2025-243 - Rev 00 | 2026/02/06 | Valid | 06/02/2031 | Chemical | 2026/02/06 | New application|CEP granted|06/02/2026 | |
| . | Purified bovine Haemoglobin, Compound 800 (C-800) | BIOS BIOTECHNOLOGY COMPANY LTD. Hong Kong Island HK | 100054542;100096660 | CEP 2020-428 - Rev 01 | 2026/02/05 | Valid | 26/10/2026 | TSE | 2026/02/05 | Transfer of holdership|CEP granted|05/02/2026; Major revision|Accepted - CEP remains valid|07/08/2025; New application|CEP granted|26/10/2021 |
|
| 1246 | Nitrendipine | EGIS Pharmaceuticals PLC Budapest X HU | 100001091;100001662 | CEP 2019-209 - Rev 02 | 2026/02/05 | Valid | Chemical | 2026/02/05 | Monograph revision|CEP granted|05/02/2026; Renewal|CEP granted|18/06/2025; Notification|Accepted - CEP remains valid|29/07/2022; Minor revision|Accepted - CEP remains valid|20/11/2020 |
||
| 758 | Colchicine | CHEMICAL RESOURCES Panchkula IN | 100048957;100082031 | CEP 2023-446 - Rev 00 | 2026/02/05 | Valid | 05/02/2031 | Chemical | 2026/02/06 | New application|CEP granted|06/02/2026 | |
| 2600 | Olmesartan medoxomil, Micronised | YANTAI VALIANT PHARMACEUTICAL CO. LTD. Yantai CN | 100044353;100073319 | CEP 2024-350 - Rev 01 | 2026/02/05 | Valid | 26/01/2031 | Chemical | 2026/02/05 | Administrative procedure|CEP granted|05/02/2026; New application|CEP granted|26/01/2026 |
|
| 1569 | Sufentanil | SPECGX LLC Webster Groves US | 100017269;100031662 | CEP 2019-054 - Rev 01 | 2026/02/05 | Valid | Chemical | 2026/02/05 | Renewal|CEP granted|05/02/2026; Minor revision|Accepted - CEP remains valid|08/04/2024 |
||
| 2866 | Gefitinib | SAKAR HEALTHCARE LIMITED Ahmedabad IN | 100033943;100085048 | CEP 2024-578 - Rev 00 | 2026/02/05 | Valid | 05/02/2031 | Chemical | 2026/02/05 | New application|CEP granted|05/02/2026 | |
| 2857 | Trazodone hydrochloride | MAHI DRUGS PRIVATE LIMITED Hyderabad IN | 100048039;100079525 | CEP 2024-399 - Rev 00 | 2026/02/05 | Valid | 05/02/2031 | Chemical | 2026/02/05 | New application|CEP granted|05/02/2026 | |
| 1654 | Lymecycline | VIRDEV INTERMEDIATES PVT. LTD. Surat IN | 100049143;100082993 | CEP 2024-386 - Rev 00 | 2026/02/05 | Valid | 05/02/2031 | Chemical | 2026/02/05 | New application|CEP granted|05/02/2026 | |
| 2631 | Rosuvastatin calcium, Process III | NINGBO MENOVO PHARMACEUTICAL CO., LTD. Ningbo CN | 100030313;100047776 | CEP 2025-486 - Rev 00 | 2026/02/05 | Valid | 05/02/2031 | Chemical | 2026/02/05 | New application|CEP granted|05/02/2026 | |
| 1491 | Amlodipine besilate, Process II | NOVARTIS PHARMA AG Basel CH | 100003908;100000364 | CEP 2008-122 - Rev 03 | 2026/02/04 | Valid | Chemical | 2026/02/04 | Monograph revision|CEP granted|04/02/2026; Notification|CEP granted|14/12/2023; Minor revision|Accepted - CEP remains valid|29/08/2022 |
||
| 388 | Dexamethasone, Crystalline Form-B | XI’AN GUOKANG RUIJIN PHARMACEUTICAL CO., LTD. Xi’an CN | 100039231;100096104 | CEP 2023-244 - Rev 00 | 2026/02/04 | Valid | 04/02/2031 | Chemical | 2026/02/04 | New application|CEP granted|04/02/2026 | |
| 2577 | Oxcarbazepine, Micronised and non-micronised | HUBEI GEDIAN HUMANWELL PHARMACEUTICAL CO., LTD. Ezhou CN | 100015482;100024200 | CEP 2018-165 - Rev 05 | 2026/02/04 | Valid | Chemical | 2026/02/04 | Minor revision|CEP granted|04/02/2026; Administrative procedure|CEP granted|02/12/2024; Minor revision|CEP granted|21/11/2024; Renewal|CEP granted|03/10/2024; Minor revision|CEP granted|07/07/2023 |
||
| 942 | Omeprazole, Micronised and sieved grade | ESTEVE QUIMICA S.A. Barcelona ES | 100002266;100056508 | CEP 1998-145 - Rev 12 | 2026/02/04 | Valid | Chemical | 2026/02/04 | Notification|CEP granted|04/02/2026; Minor revision|CEP granted|12/07/2024; Notification|Accepted - CEP remains valid|20/04/2023; Transfer of holdership|CEP granted|16/03/2022; Notification|Accepted - CEP remains valid|04/11/2021; Notification|CEP granted|24/03/2020 |
||
| 2932 | Rivaroxaban | HETERO DRUGS LIMITED Hyderabad IN | 100008415;100014434 | CEP 2023-231 - Rev 02 | 2026/02/04 | Valid | 19/11/2029 | Chemical | 2026/02/04 | Administrative procedure|CEP granted|04/02/2026; Minor revision|CEP granted|26/01/2026; Notification|Rejected|17/12/2025; Minor revision|Accepted - CEP remains valid|10/07/2025; New application|CEP granted|19/11/2024 |
|
| 859 | Pyrazinamide | ANUH PHARMA LIMITED Mumbai IN | 100021566;100030259 | CEP 2005-059 - Rev 04 | 2026/02/04 | Valid | Chemical | 2026/02/04 | Notification|CEP granted|04/02/2026; Minor revision|CEP granted|30/04/2020 |
||
| 401 | Levothyroxine sodium hydrate | MSN LABORATORIES PRIVATE LIMITED Kardanur Village IN | 100011732;100023530 | CEP 2025-250 - Rev 00 | 2026/02/04 | Valid | 04/02/2031 | Chemical | 2026/02/04 | New application|CEP granted|04/02/2026 | |
| 2756 | Amorolfine hydrochloride | ZHEJIANG CDMO PHARMACEUTICAL CO., LTD Jinhua CN | 100051857;100091157 | CEP 2024-449 - Rev 00 | 2026/02/04 | Valid | 04/02/2031 | Chemical | 2026/02/04 | New application|CEP granted|04/02/2026 | |
| 2931 | Sorafenib tosilate | KINHOO PHARMACEUTICAL CO., LTD. Zhuhai CN | 100050160;100087573 | CEP 2024-398 - Rev 00 | 2026/02/04 | Valid | 04/02/2031 | Chemical | 2026/02/04 | New application|CEP granted|04/02/2026 |
请输入需要查询的英文物质名称,证书持有人,证书编号,专论编号